| HGNC Family | Non-coding RNAs |
| Name | small Cajal body-specific RNA 5 |
| Description | Predicted to be involved in RNA processing. Located in Cajal body. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nCortistatin, a neuropeptide sharing structural similarities with somatostatin yet acting through distinct receptor mechanisms (e.g. via the ghrelin receptor GHS-R1a), plays a central role in the regulation of endocrine and metabolic functions. Evidence from transgenic and knockout mouse models indicates that endogenous cortistatin modulates pituitary hormone release—including prolactin, growth hormone, and adrenocorticotropic hormone—in a gender‐ and metabolic state–dependent manner. In addition, cortistatin influences glucose–insulin homeostasis and governs the expression and activity of the ghrelin system in endocrine tissues such as the pancreas, underscoring its role in metabolic regulation and obesity‐associated adaptations."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the central nervous system, cortistatin is expressed by specific cortical and hippocampal GABAergic interneurons where it contributes both to sleep homeostasis and to the maintenance of excitatory/inhibitory balance. Brain-derived neurotrophic factor (BDNF) signaling via TrkB receptors on these cortistatin-containing cells is essential for promoting excitatory drive, thereby preventing hyperexcitability and epileptogenesis. These mechanisms not only sustain normal sleep architecture and slow-wave activity but also provide a safeguard against seizure development."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its endocrine and neural roles, cortistatin exerts potent anti-inflammatory and analgesic effects in both the peripheral and central nervous systems. It modulates vascular smooth muscle cell proliferation and calcification, contributes to pain control by acting on peripheral nociceptive terminals and spinal mechanisms (including NF‑κB, protein kinase A, calcium, and Akt/ERK signaling), and limits airway inflammation in models of asthma through interactions with chemokines like CCL2. Furthermore, cortistatin’s involvement in tumor-related processes and the protection of brain endothelial cells under neuroinflammatory conditions highlights its diverse therapeutic potential."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Raphaëlle Winsky-Sommerer, Avron D Spier, Véronique Fabre, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of the human beta-amyloid precursor protein downregulates cortistatin mRNA in PDAPP mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Res (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.brainres.2004.04.082"}], "href": "https://doi.org/10.1016/j.brainres.2004.04.082"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15364032"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15364032"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "José Córdoba-Chacón, Manuel D Gahete, Ana I Pozo-Salas, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cortistatin is not a somatostatin analogue but stimulates prolactin release and inhibits GH and ACTH in a gender-dependent fashion: potential role of ghrelin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2011-1542"}], "href": "https://doi.org/10.1210/en.2011-1542"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21971153"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21971153"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Belén Chanclón, Raúl M Luque, José Córdoba-Chacón, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of endogenous cortistatin in the regulation of ghrelin system expression at pancreatic level under normal and obese conditions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0057834"}], "href": "https://doi.org/10.1371/journal.pone.0057834"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23469081"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23469081"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Raúl M Luque, José Cordoba-Chacon, Ana I Pozo-Salas, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Obesity- and gender-dependent role of endogenous somatostatin and cortistatin in the regulation of endocrine and metabolic homeostasis in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep37992"}], "href": "https://doi.org/10.1038/srep37992"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27901064"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27901064"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Keri Martinowich, Robert J Schloesser, Dennisse V Jimenez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Activity-dependent brain-derived neurotrophic factor expression regulates cortistatin-interneurons and sleep behavior."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Brain (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1756-6606-4-11"}], "href": "https://doi.org/10.1186/1756-6606-4-11"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21388527"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21388527"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Julia L Hill, Dennisse V Jimenez, Yishan Mai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cortistatin-expressing interneurons require TrkB signaling to suppress neural hyper-excitability."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Struct Funct (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00429-018-1783-1"}], "href": "https://doi.org/10.1007/s00429-018-1783-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30377803"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30377803"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Mario Duran-Prado, Maria Morell, Virginia Delgado-Maroto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cortistatin inhibits migration and proliferation of human vascular smooth muscle cells and decreases neointimal formation on carotid artery ligation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circ Res (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCRESAHA.112.300695"}], "href": "https://doi.org/10.1161/CIRCRESAHA.112.300695"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23595952"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23595952"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "María Morell, María Camprubí-Robles, Michael D Culler, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cortistatin attenuates inflammatory pain via spinal and peripheral actions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurobiol Dis (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.nbd.2013.11.022"}], "href": "https://doi.org/10.1016/j.nbd.2013.11.022"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24333694"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24333694"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Raúl M Luque, Alicia Villa-Osaba, Fernando L-López, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Lack of cortistatin or somatostatin differentially influences DMBA-induced mammary gland tumorigenesis in mice in an obesity-dependent mode."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Breast Cancer Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13058-016-0689-1"}], "href": "https://doi.org/10.1186/s13058-016-0689-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26956474"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26956474"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Cheng Qiu, Jiayi Li, Dan Luo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cortistatin protects against inflammatory airway diseases through curbing CCL2 and antagonizing NF-κB signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2020.07.088"}], "href": "https://doi.org/10.1016/j.bbrc.2020.07.088"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32811643"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32811643"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Julia Castillo-González, José Luis Ruiz, Ignacio Serrano-Martínez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cortistatin deficiency reveals a dysfunctional brain endothelium with impaired gene pathways, exacerbated immune activation, and disrupted barrier integrity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neuroinflammation (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12974-023-02908-5"}], "href": "https://doi.org/10.1186/s12974-023-02908-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37794493"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37794493"}]}]}]}
|
| Synonyms | U87 |
| NCBI Gene ID | 677775 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
SCARNA5 has 569 functional associations with biological entities spanning 3 categories (molecular profile, cell line, cell type or tissue, gene, protein or microRNA) extracted from 16 datasets.
Click the + buttons to view associations for SCARNA5 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of SCARNA5 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SCARNA5 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of SCARNA5 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of SCARNA5 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SCARNA5 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SCARNA5 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of SCARNA5 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SCARNA5 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of SCARNA5 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of SCARNA5 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SCARNA5 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of SCARNA5 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of SCARNA5 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of SCARNA5 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SCARNA5 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of SCARNA5 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |